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Abstract
We have previously reported that mouse embryonic stem cells (mESCs) do not have a functional 
IFN-based antiviral mechanism. The current study extends our investigation to the inflammatory 
response in mESCs and mESC-differentiated cells. We demonstrate that LPS, TNFα, and viral 
infection, all of which induce robust inflammatory responses in naturally differentiated cells, 
failed to activate NFκB, the key transcription factor that mediates inflammatory responses, and 
were unable to induce the expression of inflammatory genes in mESCs. Similar results were 
obtained in human ESCs (hESCs). In addition to the inactive state of NFκB, the deficiency of 
inflammatory response in mESCs is also attributed to the lack of functional receptors for LPS and 
TNFα. In vitro differentiation can trigger the development of the inflammatory response 
mechanism, as indicated by the transition of NFκB from its inactive to active state. However, a 
limited response was observed in mESC-differentiated fibroblasts only to TNFα and viral 
infection, but not to LPS. We conclude that the inflammatory response mechanism is not active in 
mESCs, and in vitro differentiation promotes only partial development of this mechanism. 
Together with our previous studies, the findings described in this paper demonstrate that ESCs are 
fundamentally different from differentiated somatic cells in their innate immunity, which may have 
important implications in developmental biology, immunology and ESC-based regenerative 
medicine.
Introduction
Characterized by their capacity to differentiate into various cell lineages (pluripotency) and 
unlimited proliferation (self-renewal), embryonic stem cells (ESCs) hold great promise as a 
cell source for cell-based regenerative medicine (1–3). Intensive research for the past two 
decades has developed strategies that promote ESC differentiation into various types of cells. 
However, ESC-differentiated cells are commonly assessed by comparison with their in vivo 
counterparts in morphology, cell marker expression, and cell-specific function. Many other 
functions, such as innate immunity, cannot be assessed unless the cells are exposed to 
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pathogens. Recent studies have reported that several major tissue cell types differentiated 
from both human and mouse ESCs have limited innate immune response to various 
pathogens and cytokines (4–9), highlighting the potential functional deficiency of in vitro 
ESC-differentiated cells, as we have recently discussed (10).
The immunoproperty of ESC-derived cells is an important consideration for their therapeutic 
application. Immunogenicity, the cause leading to the rejection of implanted cells by the 
host, has attracted much attention in the studies of ESCs and their differentiated cells (11–
13). On the other hand, only limited studies have investigated their immune and 
inflammatory responses to the host environment, despite the fact that such responses 
significantly impact the outcome of transplantation. The effects of the lack of innate 
immunity in ESC-differentiated cells remain to be evaluated; however it is likely that this 
deficiency may affect their fate and functionality when used in a clinical setting, since 
potentially they will be placed in an inflammatory area of the patient. While the attenuated 
innate immunity in ESC-differentiated cells may compromise their contribution to the tissue 
immunity, it could also be beneficial since the implanted cells would not potentiate the 
inflammatory response in the wounded area, thus avoiding further damage caused by the 
host’s adaptive immunity (11). Therefore, determining the molecular mechanisms that 
control innate immunity development and the immunoproperties of ESC-differentiated cells 
will provide valuable information for evaluating their therapeutic potential.
The innate immunity, presumably developed in most if not all mammalian cells, is known as 
the first line of an organism’s defense and plays a critical role in mobilizing the adaptive 
immunity. Cellular response to viral/bacterial pathogens and inflammatory cytokines is the 
central part of innate immunity. The lack of such function in ESC-derived cells raised 
concerns for their therapeutic application, and it also promoted studies seeking the molecular 
mechanisms in ESCs from which these cells are derived. Indeed, it has been demonstrated 
that ESCs do not show immune responses typically seen in differentiated cells when infected 
with bacteria and viruses (14,15). Our recent studies in mouse ESCs (mESCs) (16–18) and 
those from other investigators in human ESCs (hESCs) and in induced pluripotent stem cells 
(iPSCs) (19,20) demonstrated that the IFN system, the central component of innate antiviral 
immunity in differentiated somatic cells (21), is not fully developed in these cells. Therefore, 
the lack of innate immune responses to both bacterial and viral infection appears to be an 
intrinsic property of all pluripotent stem cells (10).
The cellular immune response is induced by various products from microbial pathogens. 
Immunostimuli are mainly detected by pattern recognition receptors that include TLRs and 
retinoic acid–inducible gene I (RIG-I)-like receptors (22,23). Although different 
immunostimuli are detected by distinct receptors and the signals are transduced by different 
signaling pathways, the signal transduction eventually converges at the point of NFκB 
activation. Activated NFκB, alone or together with other transcription factors, directly 
controls the transcription of IFN, inflammatory cytokines, and many other types of 
inflammatory mediators (22,24). Therefore, the activation of NFκB plays a central role in 
immune and inflammatory responses. In mammals, the NFκB family is composed of five 
related transcription factors: p50, p52, RelA, c-Rel, and RelB. They activate transcription of 
target genes through hetero- or homo-dimerization. The canonical NFκB pathway involves 
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p50/RelA (or c-Rel) and is mainly activated by pathogens and inflammatory cytokines, 
whereas the non-canonical pathway utilizes p52/RelB and is usually activated by specialized 
factors (25). Previous studies indicated that the lack of IFN expression in ESCs is partly 
attributable to the absence or low levels of expression of viral RNA receptors (17,19). Our 
recent study further demonstrated that NFκB is not activated in virus-infected mESCs, 
which explain the deficiency of IFN expression at the transcriptional level (26).
While significant progress has been made in understanding the lack of antiviral innate 
immunity in both mESCs and hESCs, little is known about the antibacterial and 
inflammatory responses in these cells. Since the NFκB pathway is commonly activated by 
various pathogens and inflammatory cytokines, we reasoned that its inactive state in ESCs 
could also account for their lack of antibacterial and inflammatory responses. However, a 
limited number of published studies have reported different results with inconsistent 
conclusions (27). In this study, we demonstrate that both mESCs and hESCs are deficient in 
mounting inflammatory responses to LPS (a bacterial endotoxin that strongly induces 
inflammatory response), TNFα (a prototype of inflammatory cytokines), and viral infection. 
In vitro differentiation can induce, but only partially, the development of the inflammatory 
response mechanism in mESC-differentiated cells. Here, we provide the molecular basis 
underlying these observations.
Materials and Methods
Cell culture
Two mESC lines, D3 and DBA252 mESCs, were used in this study. They were maintained 
in the standard mESC medium as previously described (17). The hESC line H9 (WA09) was 
obtained from WiCell Research Institute (Wisconsin). hESCs were seeded on matrigel 
(Corning) and fed daily with mTeSR media (Stem Cell Technologies). mESC-differentiated 
fibroblasts (mESC-FBs), C3H10T1/2 cells (10T1/2, a line of mouse embryonic fibroblasts, 
ATCC) and RAW264.7 cells ( ATCC) and HeLa Cells (ATCC) were cultured in DMEM 
with 10% FCS and 100 units/ml penicillin and 100 μg/ml streptomycin. The culture of 
HUVECs was previously described (4). All cells were maintained at 37 °C in a humidified 
incubator with 5% CO2.
mESC differentiation
In vitro differentiation of mESCs was carried out according to two methods that we have 
previously described, with minor modifications. The first method is ESC differentiation 
through embryoid body (EB) formation (28). Briefly, mESCs (1×105cells/ml) were 
suspended in a bacterial culture dish where they formed EBs and were differentiated for 5 
days. The EBs were transferred to gelatin-coated cell culture dishes where the cells within 
the EBs differentiate into a mixed cell population, which were collectively referred to as 
mESC-differentiated cells (mESC-DCs). Among mESC-DCs, a distinctive cell population is 
the cells that have large, flattened bodies and express α-smooth muscle actin (α-SMA). 
They were purified from the mixture based on their high adherence property. For this 
purpose, mESC-DCs were trypsinized. The resulting single cell suspension was reseeded in 
an uncoated cell culture dish, to which the large, flattened α-SMA positive cells quickly 
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attached within ~30 min. After removal of unattached cells in the medium, the attached cells 
were used for further analysis in specified experiments.
In the second method of differentiation, mESCs grown in a monolayer were directly induced 
with retinoic acid. The differentiation, purification, and characterization of mESC-FBs were 
described in our published studies (18,26). mESC-FBs between passages 10–30 were used 
for the experiments. D3 and DBA mESCs and mESC-differentiated cells (i.e. D3-FBs and 
DBA-FBs) displayed similar properties as previously characterized (18,26). Most 
experiments were performed with D3 cells and D3-FBs since D3 cells are a mESC line 
commonly used in the literature. Some key experiments were confirmed with DBA cells.
Cell treatment
ESCs (30–50% confluence), mESC-FBs and other cells (70–80% confluence) were treated 
with LPS (1 μg/ml, Sigma), human or mouse TNFα or IL1β (20 ng/ml, Peprotech), or 
actinomycin D (ActD, 0.4 μg/ml, Sigma) under the conditions specified in the individual 
experiments.
Immunocytochemistry and microscopic analysis
The immunochemistry and Western-blot analysis were performed according to our published 
methods with some modifications (28). The antibodies used in this study were purchased 
from Santa Cruz Biotechnology (RelA subunit of NFκB, IκB, and α-SMA) and BD 
Biosciences (PECAM-1). The cells were examined under a LSM 510 laser-scanning 
confocal microscope (Zeiss), a Leica Dmil Led inverted fluorescence microscope, or an 
Olympus CKx31 phase contrast microscope. The images were aquired with a digital camera 
mounted on the microscope.
Real-time quantitative polymerase chain reaction (RT-qPCR)
Total RNA was extracted using TRI-reagent (Sigma). cDNA was prepared using moloney 
murine leukemia virus reverse transcriptase (Sigma). RT-qPCR was performed using SYBR 
green ready mix (Bio-Rad) on a MX3000P RT-PCR system (Stratagene) as previously 
described (28). The mRNA levels from RT-qPCR were calculated using the comparative Ct 
method (29). β-actin was used as a calibrator for the calculation of relative mRNA of the 
tested genes. In the experiments with viruses, 18S rRNA was used due to the degradation of 
β-actin caused by viral infection. The sequences of the primer sets are as follows (F, 
forward; R, reverse):
Mouse cells—β-actin: F: 5′-CATGTACGTAGCCATCCAGGC-3′ R: 5′-
CTCTTTGATGTCACGCACGAT-3′
18s rRNA: F: 5′-GTAACCCGTTGAACCCCATT-3′ R: 5′-
CCATCCAATCGGTAGTAGCG-3′
CD14, F: 5′-CTCTGTCCTTAAAGCGGCTTAC-3′ R: 5′-
GTTGCGGAGGTTCAAGATGTT-3′
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TLR4, F: 5′-TGCACTGAGCTTTAGTGGTTGC-3′ R: 5′-
GACCCATGAAATTGGCACTCAT-3′
TNFR1, F: 5′-CCGGGAGAAGAGGGATAGCTT-3′ R: 5′-
TCGGACAGTCACTCACCAAGT-3′
ICAM1, F: 5′-GGCATTGTTCTCTAATGTCTCCG-3′ R: 5′-
GCTCCAGGTATATCCGAGCTTC-3′
IL6, F: 5′-TAGTCCTTCCTACCCCAATTTCC-3′ R: 5′-TTGGTCCTTAGCCACTCCTTC 
-3′
MCP-5: 5′-ATTTCCACACTTCTATGCCTCCT-3′ R 5′-
ATCCAGTATGGTCCTGAAGATCA--3′
Human cells—β-actin: F: 5′-CATGTACGTTGCTATCCAGGC -3′ R: 5′-
CTCCTTAATGTCACGCACGAT -3′
ICAM1, F: 5′-AGAGGTCTCAGAAGGGACCG -3′ R: 5′-
GGGCCATACAGGACACGAAG -3′
IL6, F: 5′-AACCTGAACCTTCCAAAGATGG -3′ R: 5′-TCTGGCTTGTTCCTCACTACT 
-3′
Flow cytometry
Protein analysis by flow cytometry was performed according to our published method (17). 
Anti-TLR4 and CD14 antibodies were preconjugated with PE (Biolegend). Anti-RelA 
antibodies (Sanz Cruz Biotechnology) were detected with secondary antibodies that were 
conjugated with FITC. The antibody-labelled cells were analyzed with an Accuri C6 flow 
cytometer (BD Biosicences). Isotype antibodies or cell samples without first antibody 
incubation were used as negative controls and were used as controls for fluorescence gating. 
The fluorescence intensity, which correlates with the protein level detected with its specific 
antibody, was determined and analyzed with the CFlow software.
TNFα cytotoxicity analysis
The cells were treated with TNFα or ActD alone, or they were pretreated with ActD for 30 
min, followed by treatment with TNFα for specified times. The cells were fixed with 
methanol and stained with toluidine blue. The absorbance at 630 nm of stained cells was 
measured with a Biotek ELx800 microtiter plate reader. The absorbance values, which 
correlate with the amount of cellular content (proteins/DNA), were used as an indirect 
measurement of viable cells as previously described (17).
Viral stock preparation and cell infection
Chikungunya virus (CHIKV, LR 2006 OPY1 strain) was propagated in Vero cells as 
previously described (30). The cells were infected with CHIKV at a multiplicity of infection 
(m.o.i.) of 1 and analyzed under the conditions specified in individual experiments.
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Statistical analysis
Data are presented as the mean ±SD as described in the figure legends. Statistical analysis 
was performed using a 2-tailed and paired student’s t-test. Differences are considered 
statistically significant when p < 0.05.
Results
LPS, TNFα and IL1β fail to activate NFκB in mESCs
We first investigated the response of NFκB to LPS, TNFα and IL1β, three well-known 
agents that induce the expression of inflammatory genes through the activation of NFκB. In 
resting cells, NFκB is retained in the cytoplasm by binding to IκB. Upon cell activation, IκB 
is degraded and NFκB translocates to the nucleus where it actives transcription of target 
genes. Therefore, nuclear translocation is commonly used as an indicator of NFκB activation 
(31). As shown in Fig. 1A, mESCs (DBA and D3) are characterized by their small size with 
large nucleus and clonal growth. In control cells, NFκB was detected in the cytoplasm of 
mESCs as expected. However, treatment with LPS, TNFα or IL1β did not cause a detectable 
change (Fig. 1A). In contrast, TNFα induced clear translocation of NFκB from the 
cytoplasm to the nucleus in HUVEC, used as a positive control (4) (Fig. 1B, image), 
concurrent with complete degradation of IκB, which did not take place in DBA cells (Fig. 
1B blots) or D3 cells (data not shown). The three agents did not cause detectable changes in 
NFκB cellular location within a time course from 15 min to 90 min treatment, indicating 
that none of them could activate the NFκB pathway in mESCs.
TNFα, but not LPS, induced limited activation of NFκB in mESC-DCs and mESC-FBs
We hypothesized that the lack of NFκB activation could be an intrinsic property of mESCs. 
Thus, differentiation should turn on the NFκB pathway and the developmental program that 
controls the inflammatory response. The pluripotency of mESCs is maintained by LIF. 
Removal of LIF from the culture medium triggers spontaneous differentiation (32). When 
mESCs are cultured in suspension, they grow in aggregates and form embryoid bodies 
(EBs), three-dimensional structures that resemble an early embryo (28). As shown in Fig. 
2Aa, when EBs (one is shown in the inset) were allowed to attach to the surface of a cell 
culture dish, the cells in EBs differentiated into a “round-patch” like structure in which cells 
undergo further differentiation to different cell types (which we collectively designated as 
ESC-DCs) (28). Fig. 2Aa illustrates a section of this “patch” structure where cells can be 
roughly divided into three “zones”: the cells in the center zone (Z1) are highly compacted 
with small size representing the least differentiated cells; the cells in the middle zone (Z2) 
are heterogeneous in morphology; while the cells at the peripheral zone (Z3) are large, 
flattened cells forming a relatively uniform monolayer.
To test the activation of NFκB, ESC-DCs were exposed to TNFα and LPS under conditions 
described in Fig. 1. Treated cells were double stained with an antibody against NFκB and an 
antibody against PECAM1 (an endothelial marker), or an antibody against α-SMA (a 
marker for smooth muscle cells/fibroblasts). TNFα or LPS did not induce NFκB nuclear 
translocation in the cells at zone 1 (Fig. 2Ab, zone 1, a representative nucleus is denoted 
with an arrow), or the cells at zone 2, including the endothelial cells that were assembled 
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into prototypes of vessel-like structures (Fig. 2Ab, zone 2). However, TNFα, but not LPS, 
induced detectable NFκB nuclear translocation in the cells at zone 3, where the majority of 
the cells are large, flattened α-SMA-positive cells (Fig. 2Ab, zone 3). These cells can be 
easily separated from other cell types in mESC-DCs based on their plastic-adhering 
property. TNFα-induced nuclear translocation of NFκB was confirmed in the purified α-
SMA positive cells (Fig. 2Ac).
We then examined NFκB activation in mESC-FBs, which were derived from mESCs 
through retinoic acid induced differentiation. They share extensive similarities with 10T1/2 
cells (fibroblasts isolated from a 14-day old embryo) (33,34) in cell marker expression, 
growth pattern, and morphology, as we have previously characterized (18,26). TNFα-
induced NFκB nuclear translocation is clearly demonstrated in D3-FBs, although the 
fluorescence intensity of NFκB in their nuclei is substantially lower than in 10T1/2 cells 
(Fig. 2Ba). This result indicates that NFκB has undergone the transition from an inactive 
status in mESCs to an active status in mESC-FBs. For a direct comparison, we used a co-
culture model where D3 and D3-FBs (or 10T1/2 cells) where D3 colonies can be easily 
distinguished from the large, flattened D3-FBs or 10T1/2 cells, either under a phase contrast 
or fluorescence microscope (Fig. 2Bb and Fig. 2Bc, respectively, circled cells). In control 
cells, NFκB was detected in the cytoplasm of both D3 cells and D3-FBs or 10T1/2 cells. 
TNFα-induced NFκB nuclear translocation only took place in D3-FBs and 10T1/2 cells but 
not in D3 cells (Fig. 2Bc, indicated by an arrow in D3-FBs or 10T1/2 and an arrowhead in 
D3 cells). The exclusive detection of NFκB in the nucleus of D3-FBs clearly demonstrated 
that the NFκB pathway is activated only after differentiation. A similar observation was 
made in cells that were treated with IL1β, but LPS did not induce NFκB nuclear 
translocation in D3, D3-FBs, or 10T1/2 cells (data not shown).
The effects of TNFα and LPS on the expression of inflammatory genes in mESCs, mESC-
DCs and mESC-FBs
We further analyzed the responsiveness of mESCs and their differentiated cells to LPS and 
TNFα by determining the expression of ICAM1 and IL6, two genes that are known to be 
under the transcriptional control of NFκB (35,36). As shown in Fig. 3A, neither LPS nor 
TNFα induced the expression of the two genes in D3 cells. TNFα induced a slight increase 
of ICAM1 and IL6 at 12 h incubation in mESC-DCs (2–5 fold). The effect of TNFα was 
notably increased in mESC-FBs, in which the expression of ICAM1 and IL6 was induced 
about 4 and 20 fold, respectively, but it is substantially lower than the effect of TNFα in 
10T1/2 cells at all time points tested (Fig. 3, A & B). LPS failed to induce the expression of 
the two genes in D3, D3-FBs, and even in 10T1/2 cells (Fig. 3, A & B). Similar results were 
obtained when the cells were treated with TNFα up to 100 ng/ml and LPS up to 10 μg/ml 
(data not shown). To confirm this observation, we tested the effect of LPS on RAW cells and 
HUVECs as positive controls. In both cells, LPS induced the expression of ICAM1 and IL6 
as expected (Fig. 3C). The expression levels of ICAM1 and IL6 in D3, D3-DCs, D3-FBs, 
and 10T1/2 cells were well correlated with NFκB nuclear translocation in response to LPS 
and TNFα (Fig. 1 and Fig. 2). Together, our data suggest that the differentiation process 
induced, but only partly, the development of the molecular mechanisms that mediate the 
inflammatory response.
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LPS and TNFα do not activate NFκB and are unable to induce the expression of 
inflammatory genes in hESCs
In order to determine whether the observations that we have made in mESCs also apply to 
hESCs, we analyzed the effects of LPS and TNFα on hESCs under the similar conditions as 
described in mESCs. As shown in Fig. 4 (images), TNFα strongly induced NFκB nuclear 
translocation in HeLa cells as a positive control, but it failed to induce any detectable change 
in hESCs. A similar observation was made in hESCs that were treated with LPS (data not 
shown). In response to LPS and TNFα, HeLa cells, but not hESCs, expressed ICAM1 and 
IL6 (Fig. 4, graph). These results are basically the same to the observations made in mESCs 
as illustrated in Fig. 1 and Fig. 3, indicating that the lack of inflammatory response to LPS 
and TNFα is a common feature of both mESCs and hESCs.
mESC-FBs, but not mESCs, are sensitive to TNFα cytotoxicity
TNFα is a pleiotropic cytokine that is not only involved in inflammation, but also causes 
cytotoxicity that leads to apoptosis or necrosis of certain tumor cells or infected cells (37). 
We took a different approach to further investigate the responsiveness of mESCs and mESC-
FBs to TNFα. Normal tissue cells are usually resistant to the cytotoxicity of TNFα, but they 
become susceptible when they are exposed to TNFα in the presence of transcription or 
translation inhibitors (31,38). TNFα alone at concentrations of 10–20 ng/ml did not show 
detectable toxicity in D3 cells, D3-FBs and 10T1/2 up to a 3-day incubation period, but it 
caused significant cell death of L929 cells (a fibroblast cell line that is sensitive to TNFα 
toxicity) within 24 h incubation (data not shown). However, when the cells were treated with 
TNFα in the presence of the transcription inhibitor ActD, 10T1/2 cells quickly lost viability 
within 5–6 h incubation, and about 90% of cells lost viability by 12 h. D3-FBs were 
susceptible to the cytotoxic effect but with less sensitivity (Fig. 5). It is noted that ActD 
alone caused apparent cell death of 10T1/2 and D3-FBs at 12 h. D3 cells were more 
sensitive to ActD than D3-FBs and 10T1/2 cells, since toxicity was apparent as early as 6 h. 
However, a major difference is that, unlike in 10T1/2 and D3-FBs, TNFα did not cause an 
additive effect to the toxicity caused by ActD in D3 cells (Fig. 5B, ActD vs ActD+TNF). 
These results provide additional evidence to support the conclusion that the mechanisms to 
detect and mediate the effects of TNFα are not developed in mESCs, but are promoted by 
the process of differentiation. The higher sensitivity of D3 cells to ActD toxicity is likely 
due to their rapid cell proliferation and metabolic rate that depend on the transcriptional 
activity.
Viral-infection induced inflammatory molecules in mESCs and mESC-FBs
The IFN response is the central part of the antiviral mechanism, but the inflammatory 
response is also a prominent event associated with viral infection. We have previously shown 
that mESCs do not express IFN when infected with several viruses (18,26) including 
CHIKV, which causes an inflammatory response in a mouse model and in cultured cells as 
we recently reported (39). We infected D3 cells, D3-FBs and 10T1/2 cells with CHIKV and 
analyzed the expression of several inflammatory molecules. As illustrated in Fig. 6A, 
CHIKV infection induced expression of TNFα, ICAM1, and MCP5 in 10T1/2 cells, but not 
in D3 cells. CHIKV-infected D3-FBs expressed increased levels of these molecules 
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compared with D3 cells, but at levels much lower than in 10T1/2 cells. These results 
resemble the pattern of IFN expression in those cells that were infected with CHIKV 
(18,26).
Since inflammatory cytokines play important roles in the regulation of antiviral responses, 
we further tested the effects of LPS and TNFα on the viability of CHIKV-infected cells. D3 
cells, D3-FBs and 10T1/2 cells were pretreated with LPS and TNFα under the conditions 
described in Fig. 5 followed by infection with CHIKV. As shown in Fig. 6B, CHIKV 
infection caused apparent cell death in all three types of cells; however, TNFα augmented 
CHIKV-induced cell death only in D3-FBs and 10T1/2 cells, but not in D3 cells (Fig. 6B, 
upper panel), while LPS did not show an additional effect on CHIKV-induced cell death in 
any cells tested (Fig. 6B, lower panel). These results further support the conclusion that 
mESCs are unable to mount an inflammatory response. Differentiated mESC-FBs have 
partially developed the mechanism to respond to TNFα, but they still lack the mechanism to 
respond to LPS.
Increased expression levels of LPS and TNFα receptors and NFκB during differentiation
To define the molecular basis underlying the lacking and attenuated inflammatory responses 
in mESCs and mESC-FBs, we first analyzed expression levels of TLR4 and CD14, the 
receptor and co-receptor for LPS, respectively, by flow cytometry. TLR4 was not detected in 
D3 and in D3-FBs while the expression of CD14 in D3-FBs was slightly higher than in D3 
cells (Fig. 7A). For comparison, we analyzed TLR4 and CD14 in RAW cells, which have 
been shown to respond to LPS (Fig. 3C). It is noted that TLR4 was expressed at a low level 
in RAW cells, but the difference is that its expression, as well as the expression of CD14, 
were significantly stimulated by LPS in RAW cells, but not in D3 and D3-FBs (Fig. 7B). 
These results explain the unresponsiveness of D3 and D3-FBs to LPS. We also determined 
the relative expression of TLR4, CD14 and TNFα receptor 1 (TNFR1, the receptor that 
mediates the inflammatory response of TNFα,) by RT-qPCR. The mRNA of the three 
molecules tested was expressed at the lowest levels in D3 cells, but increased several fold in 
D3-FBs to levels comparable to 10T1/2 cells (Fig. 7D, upper panel). It is interesting that the 
mRNA of TLR4 was not translated to functional TLR4 in D3-FBs. In the case of NFκB, its 
protein is readily detected in undifferentiated mESCs as indicated by immunofluorescence 
microscopy. This is confirmed by flow cytometry. The expression of NFκB was further 
upregulated in D3-FBs (Fig. 7C, indicated by the increased fluorescence intensity of the 
profile, D3 vs D3-FBs) to a level comparable to 10T1/2 cells. α-SMA as a marker of 
fibroblasts was extensively expressed in both D3-FBs and 10T1/2 cells (Fig. 7C). Therefore, 
the transition of NFκB from an inactive state in mESCs to an active state during 
differentiation is evident by its nuclear translocation and by its increased expression.
We have noticed that the expression levels of TLR4 and TNFα receptors in D3-FBs slightly 
increase at higher passages, indicating that the signaling mechanisms undergo further 
development during subculturing. This is better demonstrated by the experiments where 
cells were cultured for a prolonged period of time without splitting. As shown in Fig. 7D 
(lower panel), the mRNA levels of TLR4, CD14, TNFR1, and NFκB all were progressively 
upregulated in the cells that were continuously cultured for 10 and 20 days. These cells 
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showed increased induction of ICAM1 and IL6 by TNFα, but they still lack response to LPS 
(data not shown).
Discussion
A previous study has demonstrated that mESCs were susceptible to bacterial infection, but 
they did not show the immune and inflammatory responses typically displayed by somatic 
cells (14). This observation echoes the lack of IFN expression in virus-infected ESCs 
(16,19). Since NFκB is a key transcription factor that mediates a broad spectrum of immune 
and inflammatory responses induced by numerous pathogens and cytokines (40), we 
reasoned that the inactive status of NFκB in ESCs as noted in virus-infected cells could also 
account for the lack of immune and inflammatory response in bacteria-infected ESCs. 
However, studies with LPS, which has been widely used to replicate many aspects of 
bacterial infection, reported different results in ESCs. For example, Lee et al. reported that 
LPS increased cell proliferation, with its receptor TLR4 mRNA positively detected in 
mESCs (41). On the contrary, Taylor et al. showed that LPS inhibited mESC proliferation, 
but its conventional receptor TLR4 was not expressed. They proposed that the effect of LPS 
was mediated by TLR2 in the absence of TLR4 (42). On the other hand, the lack of response 
to LPS in both mESCs and hESCs, and even their differentiated cells, was also reported 
(5,6). The above-mentioned studies also disagreed on whether or not NFκB was activated by 
LPS. The only two studies that we are aware of investigating the effect of TNFα also 
reported different results. One study suggests that mESCs and their differentiated vascular 
cells lack response to TNFα (8), while the other indicates that TNFα negatively impacts 
mESC proliferation, viability and differentiation (43). While the reasons for these 
discrepancies in the published studies are not clear, the current study, based on the data 
obtained from both mESCs and their differentiated cells via multiple experimental 
approaches, clearly demonstrates that mESCs are deficient in inflammatory response and 
provide the molecular basis for such deficiency in these cells.
Although best characterized as a key transcription factor in immune and inflammatory 
responses, NFκB also regulates a wide variety of cellular events (25). The initial interest in 
NFκB in ESCs, not surprisingly, was its role in the regulation of their stem cell properties, 
i.e. pluripotency and differentiation. RelA and p50, the two subunits in the canonical NFκB 
pathway, are expressed at low levels in both mESCs and hESCs, but they are upregulated 
upon differentiation (44–47). Furthermore, the activity of NFκB is repressed by Nanog, one 
of the key pluripotency genes in hESCs (44), and by miR-290 cluster in mESCs (48). These 
studies suggest that NFκB activity in ESCs is repressed as a mechanism to maintain 
pluripotency. Although none of the aforementioned studies investigated the role of NFκB in 
the context of innate immunity, their results support our conclusions. It is interesting that a 
recent study reported that hESCs were unable to respond to LPS, like we described in 
mESCs in this study, but the NFκB pathway seemed to be functional (5), which is in 
contrary to another study showing that NFκB is not activated by TNFα in hESCs (47). The 
reasons for these different results are not clear since the two studies used different hESC 
lines and assays. Our data from hESCs clearly illustrate that they are similar to mESCs in 
the lack of NFκB activation and inflammatory response to LPS and TNFα. These results are 
also in accordance with the fact that both mESCs and hESCs are deficient in the expression 
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of type I IFN in antiviral response, which is an NFκB-dependent process (10). Considering 
the highly conserved role of NFκB in innate immunity among different species of 
vertebrates (40), our findings suggest that the lack of NFκB activation in response to 
immune and inflammatory stimuli is likely an intrinsic property of both hESCs and mESCs.
In addition to the inactive status of NFκB, the absent or low level expression of LPS and 
TNFα receptors apparently is another factor contributing to the deficiency of inflammatory 
response in mESCs. The differentiation process promoted the transition of NFκB to a 
functional status along with increased expression of NFκB. The results from experiments 
with TNFα provide a correlation among the expression levels of ICAM1 and IL6, NFκB 
nuclear translocation, and the expression levels of TNFR1 in mESCs, ESC-DCs and ESC-
FBs. Zampetaki et al. reported that mESCs and even mESC-differentiated endothelial cells 
generated through EB differentiation were not responsive to TNFα (8). This result is similar 
to our observation in EB-differentiated endothelial cells. However, we are able to 
demonstrate that mESC-FBs are responsive to TNFα. Therefore, the inflammatory response 
mechanism is a developmentally regulated process that is affected by differentiation format, 
duration, and cell type. While this study mainly used TNFα, the selected experiments 
performed with IL1β showed similar results, indicating that the conclusions from TNFα 
could apply to other inflammatory cytokines whose actions depend on the activation of 
NFκB.
mESCs, mESC-DCs and mESC-FBs all failed to show detectable responses to LPS, even in 
mESC-FBs that have a functional NFκB. This result can be explained by the lack of 
functional TLR4 expression in mESCs and mESC-FBs. It is intriguing that the mRNA of 
TLR4 was expressed, but it is not translated into functional proteins. The lack of LPS-
induced gene expression is also noted in hESCs and their differentiated vascular cells (5). 
Studies have shown that primary mouse embryonic fibroblasts (MEFs) are responsive to 
LPS (49,50). We are uncertain at this time whether or not the lack of response of mESC-FBs 
to LPS is related to in vitro differentiation, since a similar observation was made in 10T1/2 
cells. In addition to the results obtained from LPS and TNFα, the lack of inflammatory 
response in mESCs was also demonstrated in response to viral infection, similar to the lack 
of IFN expression in CHIKV-infected mESCs (18,26).
While the biological implications for the lack of IFN-based antiviral response and 
inflammatory response remain to be fully appreciated, it is not entirely surprising 
considering the fact that inflammatory cytokines and IFN are primarily produced for the 
purpose of defense and are negative regulators of growth and development (51). It is logical 
for ESCs not to produce these molecules at a developmental stage when cell proliferation 
and differentiation are major events, especially when ESCs reside in the womb where they 
could be protected by the mother’s immune system (52). In this view, the innate immunity is 
not “innate” in ESCs, but it is rather developmentally acquired during differentiation by 
somatic cells, at least in cases of IFN-based antiviral and inflammatory mechanisms. The 
recent studies on this subject have led to the notion that ESCs and differentiated somatic 
cells may have adapted distinct defense mechanisms at different stages of organismal 
development (27,53).
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Together with previous studies (4–9, 26), our data demonstrate that commonly used in vitro 
differentiation methods only partially promote the development of innate immune response 
mechanisms. Questions remain as to how and to what degree the attenuated innate immunity 
may affect their therapeutic potential. To fully understand these questions, it will be essential 
to have a complete characterization of ESC-derived cells by in vitro and in vivo studies. 
Eventually, human cells will have to be used for therapeutic applications. However, like in 
many other areas of biomedical research, the knowledge derived from mouse models has 
been instrumental to understanding human physiology and diseases. The knowledge derived 
from the studies of mESCs and mESC-differentiated cells will be valuable for developing 
strategies to obtain clinically usable cells from human pluripotent stem cells.
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Fig. 1. NFκB is not activated by TNFα, IL1β or LPS in mESCs
A, mESCs (D3 and DBA) were treated with TNFα (TNF), IL1β (IL1), or LPS for 20 min or 
left untreated (CON). The cellular location of NFκB was analyzed with an antibody against 
NFκB (RelA subunit) under a fluorescence microscope. B, Images: TNFα-induced NFκB 
nuclear translocation in HUVEC. Cells were treated and analyzed for cellular location of 
NFκB under the conditions described in A. Blots: HUVEC and DBA cells were treated with 
TNFα for 20 min. The level of IκB was analyzed by Western-blot. The lower portions of the 
blots were the stained proteins with Ponceau S to show the loading of the protein samples. In 
both A and B, an arrow indicates the location of a representative nucleus. Scale bars = 20 
μm. The images are from representative experiments performed at least two times.
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Fig. 2. Differentiation of mESCs and the effects of TNFα and LPS on NFκB activation in mESCs 
and their differentiated cells
A, Differentiation of mESC-DCs through EB formation a, The morphology of mESC-DCs 
generated from EB (inset) located at different zones (Z1, Z2 and Z3). b, Immunolocalization 
of NFκB (green), endothelial cells (PECAM1, red) and α-SMA positive cells (SMA, red) at 
different zones. c, Purified SMA-positive cells were double-stained with antibodies against 
NFκB (green) and SMA (Red). In b and c, the cells were treated with TNFα for 15 min or 
LPS for 30 min. CON, represents control cells that were not treated. An arrow indicates the 
location of a representative nucleus. B, TNFα-induced activation of NFκB in mESC-FBs but 
not in mESCs. a, D3-FBs and 10T1/2 cells were treated with TNFα for 20 min. The cellular 
location of NFκB was analyzed with antibodies. An arrow indicates the location of a 
representative nucleus. b, D3 and D3-FBs (or 10T1/2, not shown) were grown in a co-
culture where D3 cells were identified by their clonal growth (circled area) and D3-FBs 
were identified by their flattened, large cell bodies under a phase contrast microscope. c, The 
cells in the co-culture were treated with TNFα and analyzed for the cellular location of 
NFκB as described in a. In CON, NFκB is mainly detected in the cytoplasm of all cells 
tested. TNFα-induced NFκB nuclear translocation only took place in D3-FBs and 10T1/2 
cells (a, c, indicated by arrows) but not in D3 cells (c, indicated by arrowhead). Scale bars = 
20 μm. The images are from representative experiments performed at least two times.
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Fig. 3. TNFα− and LPS-induced expression of ICAM1 and IL6 in mESCs and mESC-
differentiated cells
Cells were treated with TNFα and LPS for 12 h (A), 24 h and 48 h (B). 10T1/2 cells were 
used for comparison. To confirm the effect of LPS, RAW cells and HUVEC were treated 
with LPS (5 h and 12 h, respectively). The expression of ICAM1 and IL6 was determined by 
RT-qPCR (C). The results are expressed as fold-activation where the mRNA level in the 
control of each set of experiments is designated as 1 (not shown). The values are mean ± SD 
of representative experiments performed in triplicate that were repeated at least three times.
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Fig. 4. NFκB is not activated by TNFα or LPS in hESCs
Images, hESCs and HeLa cells were treated with TNFα (TNF) or LPS for 20 min or left 
untreated (CON). The cellular location of NFκB was analyzed with an antibody against 
NFκB (RelA subunit) under a fluorescence microscope. An arrow indicates the location of a 
representative nucleus. Scale bars = 20 μm. Graph, hESCs and HeLa cells were treated with 
TNFα and LPS for 12 h and 24 h. The expression of ICAM1 and IL6 was determined by 
RT-qPCR. The results are expressed as fold-activation where the mRNA level in the control 
cells (CON, without any treatment) is designated as 1. The values are mean ± SD of a 
representative experiment performed in triplicate that were repeated two times.
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Fig. 5. mESCs are insensitive to TNFα cytotoxicity
D3 cells, D3-FBs and 10T1/2 cells were preincubated with ActD for 30 min followed by 
treatment with TNFα for the indicated times. A, Cell viability was determined by toluidine 
blue staining. *p<0.05, compared between cells treated with ActD and cells treated with 
ActD+TNF. The values are mean ± SD of a representative experiment performed in triplicate 
that was repeated at least three times. B, The morphology of cells was examined at 12 h 
treatment and photographed under a phase contrast microscope (400x).
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Fig. 6. Viral infection-induced expression of inflammatory molecules in mESCs and mESC-FBs 
and the effect of LPS and TNFα
A, D3, D3-FBs and 10T1/2 cells were infected with CHIKV (m.o.i.=1) for 20 h. The mRNA 
levels of tested genes were determined by RT-qPCR and compared with their mRNA levels 
in cells without infection (Con, designated as 1). B, D3 cells, D3-FBs and 10T1/2 cells were 
preincubated with TNFα (upper panel) or LPS (lower panel) for 3 h followed by CHIKV 
infection for 20 h. Cell viability was determined by toluidine blue staining. *p<0.05, 
compared between cells infected with CHIKV in the presence or absence of TNFα or LPS. 
D’Angelo et al. Page 21
J Immunol. Author manuscript; available in PMC 2018 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
The values are mean ± SD of a representative experiment performed in triplicate that was 
repeated two times.
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Fig. 7. Differentiation induced up-regulation of signaling molecules that regulate inflammatory 
responses
A, The expression levels of TLR4 and CD14 in D3, D3-FBs and RAW cells were 
determined by flow cytometry (the lines denoted with arrows). The lines denoted with 
arrowheads are negative controls. B, The effect of LPS on the expression of TLR4 and 
CD14. The expression levels of TLR4 and CD14 in control cells and in cells that were 
treated with LPS for 20 h were determined by flow cytometry. The lines denoted with 
arrowheads represent the negative controls. C, The expression levels of NFκB and α-SMA 
in D3, D3-FBs and 10T1/2 cells determined by flow cytometry (denoted with arrows). The 
lines denoted with arrowheads are negative controls. D, Upper panel, the relative mRNA 
levels of indicated genes in D3, D3-FBs and 10T1/2 cells were determined by RT-qPCR. 
The mRNA level of each gene was normalized to β-actin in each cell type. *p<0.05, 
compared with D3 cells. Lower panel, Long-term culture induced upregulation of the 
indicated genes in D3-FBs was determined by RT-qPCR and compared with their mRNA 
levels in the cells before the long-term culture (0 day, designated as 1, *p<0.05). The values 
are mean ± SD of representative experiments performed in triplicate that were repeated at 
least two times.
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